SRL
CPRX

Scientech Research LLC’s Catalyst Pharmaceutical CPRX Stock Holding History

Scientech Research LLC’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-26,423
Closed -$521K – 565
2025
Q3 		$521K Buy
26,423
+8,089
+44% +$166K 0.18% 251
2025
Q2 		$398K Buy
+18,334
New +$433K 0.1% 383
2024
Q4 		– Sell
-16,780
Closed -$334K – 624
2024
Q3 		$334K Buy
+16,780
New +$311K 0.07% 459

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Scientech Research LLC's CPRX Position: Q4 2025 in Review

Scientech Research LLC sold out of Catalyst Pharmaceutical (CPRX) in Q4 2025, closing a stake of 26,423 shares — an estimated $521K sold.

Scientech Research LLC first reported a position in CPRX in Q3 2024 and held it in 3 quarters. The position peaked at $521K in Q3 2025. 373 funds tracked by Wall St. Rank hold CPRX as of Q4 2025.

  • Scientech Research LLC reported no remaining Catalyst Pharmaceutical position as of Q4 2025 after selling out during the quarter.
  • Scientech Research LLC sold 26,423 Catalyst Pharmaceutical shares in Q4 2025, an estimated $521K.
  • Scientech Research LLC first reported a position in Catalyst Pharmaceutical in Q3 2024 and held it in 3 quarters.
  • Scientech Research LLC's Catalyst Pharmaceutical position peaked at $521K in Q3 2025.
  • 373 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q4 2025.

Based on Scientech Research LLC's 13F filing for Q4 2025, filed 17 Feb 2026.